Maintaining Innovation and Safe Technologies Act
Maintaining Innovation and Safe Technologies Act
Plain Language Summary
# Summary of HR 193: Maintaining Innovation and Safe Technologies Act **What the Bill Does** This bill would require Medicare (the federal health insurance program for seniors and some disabled people) to create clear payment guidelines for remote monitoring devices that use artificial intelligence—such as smart glucose monitors that send health data directly to doctors. Currently, Medicare lacks specific guidance on how it will pay for these increasingly common AI-enabled medical devices, which creates uncertainty for both patients and manufacturers. **Who It Affects** The bill primarily affects Medicare beneficiaries (roughly 67 million seniors and eligible disabled individuals) who could benefit from using these advanced monitoring devices, as well as medical device manufacturers developing and selling AI-powered health technology. Healthcare providers who use these devices would also be impacted by clearer payment rules. **Current Status** The bill is currently in committee, meaning it has been introduced but has not yet been debated or voted on by the full House of Representatives.
It was sponsored by Rep. David Schweikert (R-Arizona).
CRS Official Summary
Maintaining Innovation and Safe Technologies ActThis bill requires the Centers for Medicare & Medicaid Services (CMS) to issue guidance on payment requirements for certain remote monitoring devices (e.g., glucose monitors) under Medicare medical services. Specifically, the CMS must issue guidance on payment requirements for devices that use artificial intelligence components and that transmit information to health care providers.
Latest Action
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.